Gaucher Disease
Publisher
Springer New York
Reference66 articles.
1. Altarescu, G., Renbaum, P., Eldar-Genva, T., et al. (2010). Preimplantation genetic diagnosis (PGD) for a treatable disorder: Gaucher disease type 1 as a model. Blood Cells, Molecules & Diseases, 46, 15–18. 2. Altunbas, G., Ercan, S., Inanç, I. H., et al. (2015). Extensive vascular and valvular involvement in Gaucher disease. Asian Cardiovascular & Thoracic Annals, 23, 446–448. 3. Balicki, D., & Beutler, E. (1995). Gaucher disease. Medicine (Baltimore), 74, 305–323. 4. Balwani, M., Burrow, T. A., Charrow, J., et al. (2016). Recommendations for the use of eliglustat in the treatment of adults with Gaucher disease type 1 in the United States. Molecular Genetics and Metabolism, 117, 95–103. 5. Barranger, J. A., & O’Rourke, E. (2001). Lessons learned from the development of enzyme therapy for Gaucher disease. Journal of Inherited Metabolic Disease, 24(Suppl 2), 89–96 (discussion 87–88).
|
|